Study design
ADHD
This study was a 12-week randomized controlled trial set as a prospective, parallel, open-label study conducted from June 2020 to October 2021 on pediatric and adolescent outpatients with ADHD. The trial was registered at ClinicalTrials.gov (identifier: NCT04167995, on 19/11/2019). The study’s reporting complies with the Consolidated Standards of Reporting Trials 2010 statement [